We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-7.72%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.23B
AUM Growth
-$1.55B
Cap. Flow
-$489M
Cap. Flow %
-5.3%
Top 10 Hldgs %
9.23%
Holding
885
New
56
Increased
314
Reduced
330
Closed
89

Top Buys

Rank Stock Value
1
FC icon
Franklin Covey
FC
+$26.3M
2
VSTS icon
Vestis
VSTS
+$25M
3
FTAI icon
FTAI Aviation
FTAI
+$24M
4
AAON icon
Aaon
AAON
+$18.5M
5
WD icon
Walker & Dunlop
WD
+$18.2M

Top Sells

Rank Stock Value
1
ZD icon
Ziff Davis
ZD
+$40.2M
2
KD icon
Kyndryl
KD
+$29.1M
3
SSTK icon
Shutterstock
SSTK
+$25.2M
4
ESE icon
ESCO Technologies
ESE
+$22.3M
5
CCRN
Cross Country Healthcare
CCRN
+$21.3M

Sector Composition

Rank Sector Weight
1 Industrials 24.75%
2 Technology 18.69%
3 Financials 16.87%
4 Consumer Discretionary 12.27%
5 Healthcare 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HELE icon
701
Helen of Troy
HELE
$656M
$767K 0.01%
14,333
+8,393
+141% +$485K
SYNA icon
702
Synaptics
SYNA
$4.05B
$766K 0.01%
12,024
-14,578
-55% -$1.06M
PFS icon
703
Provident Financial Services
PFS
$3.14B
$766K 0.01%
44,601
SOLV icon
704
Solventum
SOLV
$15.3B
$760K 0.01%
10,000
-15,000
-60% -$1.12M
SCHL icon
705
Scholastic
SCHL
$774M
$754K 0.01%
39,951
-7,440
-16% -$149K
MMM icon
706
3M
MMM
$91.8B
$734K 0.01%
5,000
-6,000
-55% -$882K
CRVL icon
707
CorVel
CRVL
$3.18B
$730K 0.01%
6,521
+2,981
+84% +$333K
EGBN icon
708
Eagle Bancorp
EGBN
$850M
$702K 0.01%
33,437
-13,885
-29% -$330K
CRC icon
709
California Resources
CRC
$4.49B
$698K 0.01%
15,880
-5,406
-25% -$257K
OMCL icon
710
Omnicell
OMCL
$1.88B
$679K 0.01%
19,417
AVTR icon
711
Avantor
AVTR
$9.73B
$671K 0.01%
+41,403
New +$784K
BALL icon
712
Ball Corp
BALL
$17.5B
$654K 0.01%
+12,560
New +$659K
INSW icon
713
International Seaways
INSW
$4.68B
$640K 0.01%
+19,287
New +$706K
RHI icon
714
Robert Half
RHI
$4.11B
$637K 0.01%
11,685
CRL icon
715
Charles River Laboratories
CRL
$11.3B
$623K 0.01%
+4,140
New +$694K
FSBW icon
716
FS Bancorp
FSBW
$326M
$617K 0.01%
+16,230
New +$635K
EMBC icon
717
Embecta
EMBC
$218M
$609K 0.01%
47,762
-6,016
-11% -$96.3K
HP icon
718
Helmerich & Payne
HP
$3.34B
$600K 0.01%
22,976
-117,747
-84% -$3.42M
PTGX icon
719
Protagonist Therapeutics
PTGX
$8.55B
$593K 0.01%
+12,255
New +$514K
CRI icon
720
Carter's
CRI
$1.43B
$588K 0.01%
+14,381
New +$692K
FBP icon
721
First Bancorp
FBP
$4.41B
$581K 0.01%
+30,324
New +$589K
OSG
722
Octave Specialty Group
OSG
$257M
$579K 0.01%
66,122
-6,812
-9% -$71.7K
WEX icon
723
WEX
WEX
$6.42B
$578K 0.01%
3,680
-6,290
-63% -$1.04M
ODP
724
DELISTED
ODP
ODP
$575K 0.01%
40,157
-235,254
-85% -$4.51M
FBNC icon
725
First Bancorp
FBNC
$2.61B
$562K 0.01%
14,000

Similar funds

Royce & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Royce & Associates held 885 positions worth $9.23B, down 14% from $10.8B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Royce & Associates withdrew a net $489M in Q1 2025, closing 89 positions and reducing 330 holdings. Its most notable exit was Shutterstock, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Aaon worth $14M.

  • Royce & Associates's largest Q1 2025 buy was Aaon: 179,175 shares worth $14M.
  • Royce & Associates added most to Franklin Covey in Q1 2025, an estimated $26.3M increase.
  • Royce & Associates's biggest Q1 2025 reduction was Ziff Davis, cutting an estimated $40.2M.
  • Royce & Associates fully exited Shutterstock in Q1 2025, selling an estimated $25.2M.
  • Royce & Associates's ten largest holdings make up 9.2% of its $9.23B portfolio in Q1 2025.
  • Royce & Associates opened 56 new positions and closed 89 in Q1 2025.
  • Royce & Associates's portfolio value fell 14% quarter-over-quarter to $9.23B.

Based on Royce & Associates's 13F filing for Q1 2025, filed 6 May 2025.